Matthew Moore
Corporate Officer/Principal bij ARCUTIS BIOTHERAPEUTICS, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Matthew Moore is currently the Chief Business Officer & Senior Vice President at Arcutis Biotherapeutics, Inc. He previously worked as the Vice President-Corporate Business Development at Allergan Ltd.
(Ireland).
He completed his undergraduate degree at Trinity College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-03-2024 | 146 020 ( 0.13% ) | 1 M $ | 31-03-2024 |
Actieve functies van Matthew Moore
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 11-01-2021 |
Eerdere bekende functies van Matthew Moore
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | - |
Opleiding van Matthew Moore
| Trinity College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
